Supported in part by the National Institutes of Health/National Cancer Institute through Cancer Center Support Grant P30CA016672 to The University of Texas MD Anderson Cancer Center. P.M. and E.B.L.
Reply to: Optimizing Allogeneic Chimeric Antigen Receptor T-Cell Persistence in Relapsed/Refractory Large B-Cell Lymphoma: The Role of KIR Matching Supported in part by the National Institutes of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback